1
40
8
-
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Treatment of Symptoms in Children with Q3 Conditions Scoping Review Results
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1053/ejpn.2000.0455" target="_blank" rel="noreferrer noopener">http://doi.org/10.1053/ejpn.2000.0455</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study
Publisher
An entity responsible for making the resource available
European Journal of Paediatric Neurology
Date
A point or period of time associated with an event in the lifecycle of the resource
2001
Subject
The topic of the resource
Adolescent; Adult; Antidepressive Agents; (Second-Generation) 0; (Antipsychotic Agents) 0; (Dibenzothiazepines) 0DHU5B8D6V; (Citalopram) 12794-10-4; (Benzodiazepines) 132539-06-1; (olanzapine) 2S3PL1B6UJ; (Quetiapine Fumarate) 3G0285N20N; (Pirenzepine) L6UH7ZF8HC; Risperidone; Second-Generation/ad [Administration & Dosage]; Antidepressive Agents; alertness; behavior; trajectory; characteristics; aggression
Creator
An entity primarily responsible for making the resource
Backman M L; Aberg L E; Aronen E T; Santavuori P R
Description
An account of the resource
Patients with juvenile neuronal ceroid lipofuscinosis (JNCL) often have severe psychiatric symptoms. These are common in their mid-teens and include such symptoms as anxiety and affective and psychotic disorders. The older antidepressants and antipsychotics do not seem to be effective and often cause many adverse effects. Therefore, we wanted to try the new psychotropic drugs in Finnish patients with JNCL. We also wanted to determine the profile of these drugs in this patient group. Fourteen Finnish patients with JNCL receiving psychotropic drug treatment with citalopram, risperidone, olanzapine or quetiapine, were included. The mean age at initiation of the new psychotropic drugs was 13.8 years. Indications for treatment were psychotic symptoms, affective symptoms, anxiety and an inadequate response to other psychotropic drugs, or even adverse reactions. Information on psychiatric symptoms and current treatment was gathered from interviews and from the medical records. Indications and the clinical outcome of the treatment were determined by a consensus of the assessments by parents and physicians. The psychotropic drugs most commonly used in Finnish patients with JNCL are citalopram and risperidone. The clinical outcome was good or satisfactory in 70%. The adverse effects most commonly reported were fatigue, weight gain and aggravation of extrapyramidal symptoms. Little research has been done in this area and there are no good guidelines for treatment of psychiatric symptoms in patients with JNCL. Therefore, every patient should be treated with the safest and most commonly used drugs in the lowest possible doses.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1053/ejpn.2000.0455" target="_blank" rel="noreferrer noopener">10.1053/ejpn.2000.0455</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
(Antipsychotic Agents) 0
(Benzodiazepines) 132539-06-1
(Citalopram) 12794-10-4
(Dibenzothiazepines) 0DHU5B8D6V
(olanzapine) 2S3PL1B6UJ
(Pirenzepine) L6UH7ZF8HC
(Quetiapine Fumarate) 3G0285N20N
(Second-Generation) 0
2001
Aberg L E
Adolescent
Adult
Aggression
alertness
Antidepressive Agents
Aronen E T
Backman M L
Behavior
characteristics
European Journal of Paediatric Neurology
Risperidone
Santavuori P R
Second-Generation/ad [Administration & Dosage]
Trajectory
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1001/archpsyc.61.1.34" target="_blank" rel="noreferrer">http://doi.org/10.1001/archpsyc.61.1.34</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy
Publisher
An entity responsible for making the resource available
Archives Of General Psychiatry
Date
A point or period of time associated with an event in the lifecycle of the resource
2004
Subject
The topic of the resource
Female; Humans; Male; Adult; Follow-Up Studies; Middle Aged; Sensitivity and Specificity; Personality Inventory; Antidepressive Agents; Depressive Disorder; Ambulatory Care; Outcome and Process Assessment (Health Care); Non-U.S. Gov't; Research Support; Comparative Study; Blood Glucose/metabolism; Brain Mapping; Cerebral Cortex/physiopathology/radionuclide imaging; Cognitive Therapy; Emission-Computed; Energy Metabolism/physiology; Fluorodeoxyglucose F18/diagnostic use; Frontal Lobe/physiopathology/radionuclide imaging; Limbic System/physiopathology/radionuclide imaging; Major/physiopathology/radionuclide imaging/therapy; Nerve Net/physiopathology/radionuclide imaging; Neural Pathways/physiopathology/radionuclide imaging; Paroxetine/therapeutic use; Prefrontal Cortex/physiopathology/radionuclide imaging; Second-Generation/therapeutic use; Tomography
Creator
An entity primarily responsible for making the resource
Goldapple K; Segal Z; Garson C; Lau M; Bieling P; Kennedy S; Mayberg H
Description
An account of the resource
BACKGROUND: Functional imaging studies of major depressive disorder demonstrate response-specific regional changes following various modes of antidepressant treatment. OBJECTIVE: To examine changes associated with cognitive behavior therapy (CBT). METHODS: Brain changes underlying response to CBT were examined using resting-state fluorine-18-labeled deoxyglucose positron emission tomography. Seventeen unmedicated, unipolar depressed outpatients (mean +/- SD age, 41 +/- 9 years; mean +/- SD initial 17-item Hamilton Depression Rating Scale score, 20 +/- 3) were scanned before and after a 15- to 20-session course of outpatient CBT. Whole-brain, voxel-based methods were used to assess response-specific CBT effects. A post hoc comparison to an independent group of 13 paroxetine-treated responders was also performed to interpret the specificity of identified CBT effects. RESULTS: A full course of CBT resulted in significant clinical improvement in the 14 study completers (mean +/- SD posttreatment Hamilton Depression Rating Scale score of 6.7 +/- 4). Treatment response was associated with significant metabolic changes: increases in hippocampus and dorsal cingulate (Brodmann area [BA] 24) and decreases in dorsal (BA 9/46), ventral (BA 47/11), and medial (BA 9/10/11) frontal cortex. This pattern is distinct from that seen with paroxetine-facilitated clinical recovery where prefrontal increases and hippocampal and subgenual cingulate decreases were seen. CONCLUSIONS: Like other antidepressant treatments, CBT seems to affect clinical recovery by modulating the functioning of specific sites in limbic and cortical regions. Unique directional changes in frontal cortex, cingulate, and hippocampus with CBT relative to paroxetine may reflect modality-specific effects with implications for understanding mechanisms underlying different treatment strategies.
2004
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1001/archpsyc.61.1.34" target="_blank" rel="noreferrer">10.1001/archpsyc.61.1.34</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2004
Adult
Ambulatory Care
Antidepressive Agents
Archives Of General Psychiatry
Backlog
Bieling P
Blood Glucose/metabolism
Brain Mapping
Cerebral Cortex/physiopathology/radionuclide imaging
Cognitive Therapy
Comparative Study
Depressive Disorder
Emission-Computed
Energy Metabolism/physiology
Female
Fluorodeoxyglucose F18/diagnostic use
Follow-up Studies
Frontal Lobe/physiopathology/radionuclide imaging
Garson C
Goldapple K
Humans
Journal Article
Kennedy S
Lau M
Limbic System/physiopathology/radionuclide imaging
Major/physiopathology/radionuclide imaging/therapy
Male
Mayberg H
Middle Aged
Nerve Net/physiopathology/radionuclide imaging
Neural Pathways/physiopathology/radionuclide imaging
Non-U.S. Gov't
Outcome And Process Assessment (health Care)
Paroxetine/therapeutic use
Personality Inventory
Prefrontal Cortex/physiopathology/radionuclide imaging
Research Support
Second-Generation/therapeutic use
Segal Z
Sensitivity and Specificity
Tomography
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1185/030079902125001353" target="_blank" rel="noreferrer">http://doi.org/10.1185/030079902125001353</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Focus on paroxetine
Publisher
An entity responsible for making the resource available
Current Medical Research And Opinion
Date
A point or period of time associated with an event in the lifecycle of the resource
2003
Subject
The topic of the resource
Humans; Treatment Outcome; Drug Interactions; Animals; Antidepressive Agents; Stress Disorders; Anxiety Disorders/drug therapy; Depression/drug therapy; Paroxetine/administration & dosage/adverse effects/pharmacokinetics/therapeutic use; Post-Traumatic/drug therapy; Second-Generation/administration & dosage/adverse effects/pharmacokinetics/therapeutic use; Serotonin Uptake Inhibitors/administration & dosage/adverse effects/pharmacokinetics/therapeutic use; Substance Withdrawal Syndrome
Creator
An entity primarily responsible for making the resource
Green B
Description
An account of the resource
This review of paroxetine is based on Medline and PsycLit searches and a manual search of the available research literature. It aims to cover the pharmacology of this frequently prescribed SSRI antidepressant in terms of its indications, efficacy and adverse effects. Overall, paroxetine is a well-tolerated and safe first-line SSRI antidepressant with anxiolytic qualities. It has been found useful in depression, anxiety and other conditions such as obsessive compulsive disorder and post-traumatic stress disorder. The antidepressant has some advantages over earlier tricyclic medication in terms of a lack of cardiovascular side-effects and relative safety in overdose. Cessation of use, however, is associated with withdrawal or discontinuation symptoms and patients should be counselled as to how these might be avoided. A 3- or 4-week graded withdrawal regimen, perhaps with concomitant fluoxetine to cover serotonergic discontinuation symptoms, may be advisable.
2003
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1185/030079902125001353" target="_blank" rel="noreferrer">10.1185/030079902125001353</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2003
Animals
Antidepressive Agents
Anxiety Disorders/drug therapy
Backlog
Current Medical Research And Opinion
Depression/drug therapy
Drug Interactions
Green B
Humans
Journal Article
Paroxetine/administration & dosage/adverse effects/pharmacokinetics/therapeutic use
Post-Traumatic/drug therapy
Second-Generation/administration & dosage/adverse effects/pharmacokinetics/therapeutic use
Serotonin Uptake Inhibitors/administration & dosage/adverse effects/pharmacokinetics/therapeutic use
Stress Disorders
Substance Withdrawal Syndrome
Treatment Outcome
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="www.RxFiles.ca" target="_blank" rel="noreferrer">www.RxFiles.ca</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Antidepressant comparison chart
Date
A point or period of time associated with an event in the lifecycle of the resource
2004
Subject
The topic of the resource
Drug Therapy; Antidepressive Agents; Amitriptyline; Bupropion; Citalopram; Clomipramine; Desipramine; Doxepin; Fluoxetine; Fluvoxamine; Imipramine; Moclobemide; Nortriptyline; Paroxetine; Propylamines; Serotonin Antagonists; Sertraline; Trazodone
Creator
An entity primarily responsible for making the resource
Regier L; Jensen B
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
Description
An account of the resource
2004
2004
Amitriptyline
Antidepressive Agents
Backlog
Bupropion
Citalopram
Clomipramine
Desipramine
Doxepin
Drug Therapy
Fluoxetine
Fluvoxamine
Imipramine
Jensen B
Journal Article
Moclobemide
Nortriptyline
Paroxetine
Propylamines
Regier L
Serotonin Antagonists
Sertraline
Trazodone
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1016/0165-1781(95)02674-6" target="_blank" rel="noreferrer">http://doi.org/10.1016/0165-1781(95)02674-6</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders: II. Bulimia nervosa
Publisher
An entity responsible for making the resource available
Psychiatry Research
Date
A point or period of time associated with an event in the lifecycle of the resource
1995
Subject
The topic of the resource
Female; Humans; Adult; Middle Aged; Treatment Outcome; Antidepressive Agents; Combined Modality Therapy; adolescent; Comparative Study; beta-Endorphin/blood; Cognitive Therapy; Dibenzocycloheptenes/administration & dosage; Sincalide/blood; T-Lymphocytes/drug effects/metabolism; Bulimia/blood/therapy; Fluvoxamine/administration & dosage; Serotonin Uptake Inhibitors/administration & dosage; Tricyclic/administration & dosage
Creator
An entity primarily responsible for making the resource
Brambilla F; Brunetta M; Draisci A; Peirone A; Perna G; Sacerdote P; Manfredi B; Panerai AE
Description
An account of the resource
Concentrations of cholecystokinin-8 (CCK-8) and beta-endorphin (beta-EP) in T-lymphocytes of 26 women with bulimia nervosa (BN) and in 26 age- and sex-matched healthy comparison subjects were measured. Ten patients were then treated with 300 mg/day of fluvoxamine, p.o., and five patients were treated with 300 mg/day of amineptine, p.o., for 4 months. Concentrations of the two peptides were measured again after 1, 2, and 4 months of therapy. Basal CCK-8 values were significantly lower in patients than in healthy subjects. During fluvoxamine therapy, CCK-8 values increased, reaching normal levels by month 4 of treatment. No such increase occurred during amineptine therapy. Baseline beta-EP values were normal in the bulimic patients but had declined by month 4 of fluvoxamine therapy.
1995
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/0165-1781(95)02674-6" target="_blank" rel="noreferrer">10.1016/0165-1781(95)02674-6</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
1995
Adolescent
Adult
Antidepressive Agents
Backlog
beta-Endorphin/blood
Brambilla F
Brunetta M
Bulimia/blood/therapy
Cognitive Therapy
Combined Modality Therapy
Comparative Study
Dibenzocycloheptenes/administration & dosage
Draisci A
Female
Fluvoxamine/administration & dosage
Humans
Journal Article
Manfredi B
Middle Aged
Panerai AE
Peirone A
Perna G
Psychiatry Research
Sacerdote P
Serotonin Uptake Inhibitors/administration & dosage
Sincalide/blood
T-Lymphocytes/drug effects/metabolism
Treatment Outcome
Tricyclic/administration & dosage
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1016/s0304-3959(99)00154-2" target="_blank" rel="noreferrer">http://doi.org/10.1016/s0304-3959(99)00154-2</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
Publisher
An entity responsible for making the resource available
Pain
Date
A point or period of time associated with an event in the lifecycle of the resource
1999
Subject
The topic of the resource
Humans; Animals; Antidepressive Agents; Non-U.S. Gov't; Research Support; Pain/drug therapy/etiology; Randomized Controlled Trials; Narcotics/therapeutic use; Analgesics/therapeutic use; Carbamazepine/therapeutic use; Diabetic Neuropathies/complications; N-Methylaspartate/antagonists & inhibitors/therapeutic use; Neuralgia/drug therapy; Polyneuropathies/complications; Serotonin Uptake Inhibitors/therapeutic use; Tricyclic/therapeutic use
Creator
An entity primarily responsible for making the resource
Sindrup SH; Jensen TS
Description
An account of the resource
Tricyclic antidepressants and carbamazepine have become the mainstay in the treatment of neuropathic pain. Within the last decade, controlled trials have shown that numerous other drugs relieve such pain. We identified all placebo-controlled trials and calculated numbers needed to treat (NNT) to obtain one patient with more than 50% pain relief in order to compare the efficacy with the current treatments, and to search for relations between mechanism of pain and drug action. In diabetic neuropathy, NNT was 1.4 in a study with optimal doses of the tricyclic antidepressant imipramine as compared to 2.4 in other studies on tricyclics. The NNT was 6.7 for selective serotonin reuptake inhibitors, 3.3 for carbamazepine, 10.0 for mexiletine, 3.7 for gabapentin, 1.9 for dextromethorphan, 3.4 for tramadol and levodopa and 5.9 for capsaicin. In postherpetic neuralgia, the NNT was 2.3 for tricyclics, 3.2 for gabapentin, 2.5 for oxycodone and 5.3 for capsaicin, whereas dextromethorphan was inactive. In peripheral nerve injury, NNT was 2.5 for tricyclics and 3.5 for capsaicin. In central pain, NNT was 2.5 for tricyclics and 3. 4 for carbamazepine, whereas selective serotonin reuptake inhibitors, mexiletine and dextromethorphan were inactive. There were no clear relations between mechanism of action of the drugs and the effect in distinct pain conditions or for single drug classes and different pain conditions. It is concluded that tricyclic antidepressants in optimal doses appear to be the most efficient treatment of neuropathic pain, but some of the other treatments may be important due to their better tolerability. Relations between drug and pain mechanisms may be elucidated by studies focusing on specific neuropathic pain phenomena such as pain paroxysms and touch-evoked pain.
1999
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/s0304-3959(99)00154-2" target="_blank" rel="noreferrer">10.1016/s0304-3959(99)00154-2</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
1999
Analgesics/therapeutic use
Animals
Antidepressive Agents
Backlog
Carbamazepine/therapeutic use
Diabetic Neuropathies/complications
Humans
Jensen TS
Journal Article
N-Methylaspartate/antagonists & inhibitors/therapeutic use
Narcotics/therapeutic use
Neuralgia/drug therapy
Non-U.S. Gov't
Pain
Pain/drug therapy/etiology
Polyneuropathies/complications
Randomized Controlled Trials
Research Support
Serotonin Uptake Inhibitors/therapeutic use
Sindrup SH
Tricyclic/therapeutic use
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1016/s0895-4356(96)00429-5" target="_blank" rel="noreferrer">http://doi.org/10.1016/s0895-4356(96)00429-5</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment
Publisher
An entity responsible for making the resource available
Journal Of Clinical Epidemiology
Date
A point or period of time associated with an event in the lifecycle of the resource
1997
Subject
The topic of the resource
Humans; Outcome Assessment (Health Care); Research Design; Antidepressive Agents; Cross-Over Studies; Models; Statistical; Chronic disease; Amitriptyline/therapeutic use; Bayes Theorem; Fibromyalgia/drug therapy; Randomized Controlled Trials as Topic/statistics & numerical data; Tricyclic
Creator
An entity primarily responsible for making the resource
Zucker DR; Schmid CH; McIntosh MW; D'Agostino RB; Selker HP; Lau J
Description
An account of the resource
When treating individual patients, physicians may face difficulties using the evidence from center-based randomized control trials (RCTs) due to limitations in these studies generalizability. Therefore, they often perform their own "informal" tests of treatment effectiveness. Single patient ("N-of-1") trials provide a structured design for more rigorous assessment of medical treatments of chronic diseases, but are applied only to the index patient. We present a hierarchical Bayesian random effects model to combine N-of-1 studies to obtain an estimate of treatment effectiveness for the population and to use this population information to aid in the evaluation of an individual patient's trial results. The model's treatment effect estimates are adjustments between the population estimate and the individual's observed results. This adjustment is based upon the within-patient and between-patient heterogeneity. We demonstrate this patient-focused method using published data from 23 N-of-1 trial results comparing amitriptyline and placebo for the treatment of fibromyalgia.
1997
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/s0895-4356(96)00429-5" target="_blank" rel="noreferrer">10.1016/s0895-4356(96)00429-5</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
1997
Amitriptyline/therapeutic use
Antidepressive Agents
Backlog
Bayes Theorem
Chronic Disease
Cross-Over Studies
D'Agostino RB
Fibromyalgia/drug therapy
Humans
Journal Article
Journal Of Clinical Epidemiology
Lau J
McIntosh MW
Models
Outcome Assessment (health Care)
Randomized Controlled Trials as Topic/statistics & numerical data
Research Design
Schmid CH
Selker HP
statistical
Tricyclic
Zucker DR
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&uid=10835999" target="_blank" rel="noreferrer">http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&uid=10835999</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Pain and symptom control in terminally ill children
Publisher
An entity responsible for making the resource available
Pediatric Clinics Of North America
Date
A point or period of time associated with an event in the lifecycle of the resource
2000
Subject
The topic of the resource
Child; Palliative Care; Pain Measurement; Adult; Analgesics; Antidepressive Agents; Preschool; infant; Comparative Study; Human; Opioid/therapeutic use; Tricyclic/therapeutic use; HIV Seropositivity/psychology; Anesthetics/therapeutic use; Depression/drug therapy/etiology; Gastrointestinal Diseases/therapy; Histamine H1 Antagonists/therapeutic use; Neoplasms/complications/psychology; Pain/diagnosis/drug therapy/etiology; Terminally Ill/psychology
Creator
An entity primarily responsible for making the resource
Galloway KS; Yaster M
Description
An account of the resource
The management of pain in terminally ill pediatric patients has incalculable benefits to patients, their families, and physicians and nurses. A therapeutic management plan is dependent on a thorough understanding of the causes of pain in these patients, on pain assessment, and on the myriad drugs and drug strategies that are essential in pain treatment. Aggressive symptom control of treatment- related side effects can ensure successful implementation of such a plan.
2000
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2000
Adult
Analgesics
Anesthetics/therapeutic use
Antidepressive Agents
Backlog
Child
Comparative Study
Depression/drug therapy/etiology
Galloway KS
Gastrointestinal Diseases/therapy
Histamine H1 Antagonists/therapeutic use
HIV Seropositivity/psychology
Human
Infant
Journal Article
Neoplasms/complications/psychology
Opioid/therapeutic use
Pain Measurement
Pain/diagnosis/drug therapy/etiology
Palliative Care
Pediatric Clinics of North America
Preschool
Terminally Ill/psychology
Tricyclic/therapeutic use
Yaster M